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Structure of a CXC chemokine-receptor fragment in complex with
interleukin-8
Nicholas J Skelton1*, Cliff Quan2, Dorothea Reilly3 and Henry Lowman3
Background: Interactions between CXC chemokines (e.g. interleukin-8, IL-8)
and their receptors (e.g. CXCR-1) have a key role in host defense and disease
by attracting and upregulating neutrophils to sites of inflammation. The
transmembrane nature of the receptor impedes structure-based understanding
of ligand interactions. Linear peptides based on the N-terminal, extracellular
portion of the receptor CXCR-1 do bind to IL-8, however, and inhibit the
binding of IL-8 to the full-length receptor.
Results: The NMR solution structure of the complex formed between IL-8 and
one such receptor-based peptide indicates that a cleft between a loop and a
β hairpin constitute part of the receptor interaction surface on IL-8. Nine
residues from the C terminus of the receptor peptide (corresponding to
Pro21–Pro29 of CXCR-1) occupy the cleft in an extended fashion.
Intermolecular contacts are mostly hydrophobic and sidechain mediated.
Conclusions: The results offer the first details at an atomic level of the
interaction between a chemokine and its receptor. Consideration of other
biochemical data allow extrapolation to a model for the interaction of IL-8 
with the full-length receptor. In this model, the heparin-binding residues of
IL-8 are exposed, thereby allowing presentation of the chemokine from
endothelial cell-surface glycosaminoglycans. This first glimpse of how IL-8
binds to its receptor provides a foundation for the structure-based design of
chemokine antagonists.
Introduction
The maintenance of an inflammatory response depends
upon intercellular interactions that cause localization of
leukocytes to the endothelium and extravasation into the
underlying tissue [1,2]. The chemokines are a key compo-
nent of this process by virtue of their ability to attract and
activate specific subpopulations of white blood cells [3,4].
Categorization of chemokine proteins into two subfamilies
on the basis of their amino acid sequence leads to a broad
functional demarcation: members of the CXC subfamily
contain an amino acid between two cysteine residues near
the N terminus and act mainly upon neutrophils; members
of the CC subfamily do not have a residue between the two
cysteine residues near the N terminus and act upon mono-
cytes, eosinophils or lymphocytes, but not neutrophils.
The structures of many chemokines have been solved in
solution and the crystalline state (for a review see [5]). All
have the same tertiary fold consisting of a triple-stranded
antiparallel β sheet onto which packs a C-terminal α helix
(Figure 1a). Under the conditions used to determine the
structures, oligomerization is common: CXC chemokines
generally dimerize through the N-terminal β strand to form
a six-stranded β sheet (Figure 1a), whereas CC chemo-
kines generally dimerize via the residues at the N termi-
nus prior to the CC motif [5]. The significance of the
oligomerization remains controversial in vivo, although in
vitro assays suggest that monomers of CXC chemokines
are active [6–8]. Mutagenesis studies indicate that a Glu-
Leu-Arg (ELR) sequence near the N terminus of CXC
chemokines is critical for receptor binding and signaling
[9,10]; residues in the so-called ‘N loop’ (between the CC
or CXC motif and the first β strand; see Figure 1a) have
also been shown to confer specificity to chemokines for
binding to particular receptors [11–13].
Chemokines exert their influence on leukocytes by binding
to G-protein-coupled cell-surface receptors [14,15]. More
than 30 chemokine sequences have been reported in the
literature; a smaller but growing number of receptor mole-
cules (more than ten) have been sequenced and cloned (for
a review see [16]). The distinct specificity of each chemo-
kine for the receptor types expressed on particular leuko-
cytes presumably allows fine tuning of the inflammatory
response to a particular insult to the host tissue. On the basis
of primary sequence, the chemokine receptors have been
shown to contain seven membrane-spanning helices, and
residues important for ligand and G protein binding have
been inferred from mutagenesis studies [17,18]. Recently,
several of these molecules have risen to prominence as co-
receptors to CD4-mediated human immunodeficiency virus
type 1 (HIV-1) entry into cells (reviewed in [16]).
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Interleukin-8 (IL-8) is a CXC chemokine the structure
and function of which have been studied extensively
[19]. There are two known receptors for IL-8 expressed
on neutrophils (CXCR-1 and CXCR-2; [14,15]). Struc-
tural knowledge of the interaction of IL-8 with these
receptors is scant, owing to the membrane-bound nature
of the receptor. Several recent studies, however, indicate
that peptides based on the N-terminal extracellular domain
of CXCR-1 are able to bind to IL-8, albeit with 103–104
fold weaker affinity than the full-length receptor [20–23].
Herein, we describe the structure of one such complex
determined in solution using nuclear magnetic resonance
(NMR) spectroscopy.
Results
Choice of peptide
The interaction of IL-8 with receptor fragments was first
reported for peptides corresponding to the N-terminal 37
to 43 residues of CXCR-1 and CXCR-2; the peptide
derived from CXCR-1 inhibited binding of IL-8 to cells
displaying CXCR-1 with a Ki of ~20 µM [20]. This level of
inhibition was maintained in the truncated 21-residue
peptide CXCR1-p0, corresponding to residues Met9 to
Pro29 of CXCR-1 [22]. The peptide was further reduced
by replacing Leu15, Asn16, Phe17, Thr18 and Gly19 with
a single six-amino hexanoic acid moiety [23]. This latter
peptide (CXCR1-p1) was chosen for the present study by
virtue of its small size (simplifying the NMR analysis) and
its relatively potent inhibition of IL-8 receptor binding
(Ki = 13 µM) [23]. The sequence of this peptide, and its
relationship to the complete N-terminal extracellular domain
of CXCR-1 is shown in Figure 1b. Henceforth, residues
within CXCR1-p1 will be numbered according to their
position in this peptide, rather than the position of the cor-
responding residue in CXCR-1.
CXCR1-p1 was initially analyzed by itself in H2O solu-
tion. At 27°C, all nuclear Overhauser enhanced (NOE) peak
intensities were close to zero, as expected for a peptide of
this size. Through-space information was obtained from
rotating-frame Overhauser enhanced spectra (ROESY)
[24] or from NOESY data acquired at 5°C; combining
these data with total correlation spectroscopy (TOCSY)
and correlated spectroscopy (COSY) data permitted reso-
nance assignments to be made by standard methods [25].
Only intraresidue and sequential through-space interac-
tions were observed, and all backbone scalar coupling
constants (3JHN–Hα) were in the range 6.5–7.5 Hz (data
not shown); thus, CXCR1-p1 has no well defined confor-
mation. Initial 1H NMR spectra collected on the CXCR1-
p1–IL-8 complex indicated that approximately one peptide
binds to each IL-8 monomer, that the dimer symmetry is
preserved in the complex and that the peptide resonances
are in fast exchange between the free and bound states
over the temperature range 5–40°C. NOESY experiments
were collected on peptide samples containing 0.1 equiva-
lents of unlabeled IL-8 at 27°C in the hope of observing
transferred NOEs indicative of the bound conformation
of the peptide [26]. NOE peaks were more intense than
for the free peptide and negative in sign, indicating that
the peptide was bound to IL-8 under these sample condi-
tions. However, the observed NOEs were mostly sequen-
tial and intraresidue in origin, suggesting that the peptide
binds in an extended fashion.
Assignments and chemical-shift changes
1H and 15N NMR assignments have previously been
reported for IL-8 [27,28]. Backbone resonance positions of
free IL-8 under the conditions used in the present study
(50 mM phosphate pH 5.6, 40°C) were initially made by
comparing 15N heteronuclear single quantum coherence
(HSQC) spectra to those reported previously; assignments
were confirmed and extended to include 13C signals by
the use of several backbone triple resonance experiments. 
The complex between IL-8 and the peptide was formed by
adding aliquots of a concentrated solution of the peptide to
the IL-8 sample. After the addition of each aliquot, 1H–15N
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Figure 1
Overview of the IL-8 structure and receptor N-terminal sequences.
(a) Ribbon diagram of an IL-8 dimer. The minimized mean
coordinates of Clore et al. were used (PDB code 1IL8) [30]. The two
monomers are colored white and gray; secondary structure elements
discussed in the text are labeled. (The figure was rendered with the
program MOLSCRIPT [57].) (b) The amino acid sequence of the N
terminus of human IL-8 receptor CXCR-1 and its relationship to the
peptide fragments that bind to IL-8. The sequence of CXCR-2 is
shown for comparison.
HSQC and 1H–13C constant time (CT)-HSQC spectra were
acquired (Figure 2a) so that chemical-shift changes of back-
bone atoms (HN, N, Hα, Cα) and sidechain methyl groups
could be followed. Chemical shifts stopped changing after
slightly more than 1 equivalent of peptide had been added
for each monomer of IL-8 present. Complete assignments
were obtained by repeating a subset of the triple resonance
experiments on the complex.
Peptide spin systems in the complex were initially identi-
fied in an F2-15N filtered TOCSY experiment; sequential
assignments were made from an F2-15N filtered NOESY
by standard methods [25]. These assignments were con-
firmed by analysis of an F1-13C filtered TOCSY and an
F1,F2-13C filtered NOESY acquired from D2O solution.
The chemical shift of several HN resonances of IL-8 are
shown in Figure 2b as a function of peptide concentra-
tion; the maximal change observed was 0.36 ppm for HN,
2.5 ppm for N, 0.15 ppm for Hα, 0.25 ppm for Cα and
0.37 ppm for backbone carbonyl carbons. Changes in all of
the backbone atom chemical shifts are summarized in
Figure 3. The resonances that are most affected by addi-
tion of peptide are localized to residues 9 to 21 and 42 to
49. In uncomplexed IL-8, these residues define a cleft
on the surface of the protein in which several hydro-
phobic sidechains are exposed to solvent (Ile10, Tyr13,
Phe17, Phe21, Ile40, Leu43 and Leu49). The chemical-
shift changes thus map out a likely binding site for the
peptide. A very similar binding site has also been delin-
eated by Clubb et al. by following 1H and 15N chemical-
shift changes of IL-8 as a 40-residue peptide from CXCR-1
was added [21]. The area on IL-8 affected by the addi-
tion of  peptide seems small compared to the size of a
17-residue peptide; this suggests that only part of the
peptide interacts strongly with IL-8 or that the peptide
folds back on itself when bound to IL-8.
Structure calculations
Several types of NOESY data were analyzed in order to more
completely characterize the CXCR1-p1–IL-8 complex.
The presence of uniformly high levels of 13C and 15N in
IL-8 but not in the peptide allowed many different types
of interactions to be identified in these experiments.
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Figure 2
Changes in chemical shift as CXCR1-p1 binds to IL-8. (a) 1H–15N
HSQC spectra of IL-8 (black) and IL-8 complexed to CXCR1-p1 (red)
at pH 5.6 and 308K. Several residues that undergo a significant shift
are indicated. (b) Chemical-shift changes for several amide proton
resonances of IL-8 as CXCR1-p1 is added. 
Figure 3
Summary of changes in IL-8 chemical shift upon complex formation
with CXCR1-p1. The colors run from yellow through red to blue,
indicating large, intermediate and negligible changes in chemical
shift, respectively. The color for each residue reflects an aggregate of
HN, N, Cα and C′ chemical-shift changes; for each residue, the shifts
of each nuclear type (as a fraction of the maximal changes seen for
that nuclear type for any residue) were added to determine the final
color. Secondary structure elements discussed in the text are
labeled. (This view was rendered using the NEON package within
MIDAS [58].)
Restraints within the bound peptide were obtained from
the F1 13C, F2 13C-filtered NOESY acquired from D2O
solution and an F2 15N-filtered NOESY acquired from
H2O solution. Restraints within IL-8 were obtained from
an F2 15N-edited NOESY-HSQC spectrum acquired from
H2O solution. Note that in principle, the F2 15N-filtered
NOESY spectrum and the F2 15N-edited NOESY-HSQC
spectrum could include intermolecular NOEs; although a
search was made for such interactions, none were observed.
Intermolecular contacts between the peptide and IL-8
were definitively identified in an F1 13C-edited, F3 13C-
filtered NOESY spectrum acquired from D2O solution
[29]; NOEs were only observed to the C-terminal half of
the peptide. Two sections of this NOESY spectrum are
shown in Figures 4a and b summarizes all of the observed
intermolecular NOEs.
The lack of chemical-shift change for many residues of
IL-8 (Figure 3) indicated that most of the protein has very
similar structural and dynamic properties in the presence
and absence of the peptide, hence the structure of the free
IL-8 dimer determined previously [30] was suitable as a
starting point for structure determination of the peptide
complex. During the refinement process, only residues
within and adjacent to the region of IL-8 exhibiting chem-
ical shift changes were allowed to move under the influ-
ence of the experimental restraints; all other residues were
kept fixed. Due to the symmetric nature of the complex
on the NMR time-scale, a single copy of the peptide was
modeled in an extended conformation and positioned ran-
domly 5–10 Å above the N-loop cleft of one monomer of
the IL-8 dimer, and the complex was refined by molecular
dynamics simulation including restraints based on the
observed NOEs. During the refinement, the coordinates
of the IL-8 monomer furthest from the peptide were also
kept fixed. The use of this protocol lead to a significant
saving in NOESY analysis time (only 15N-edited NOESY
peaks involving amide protons in the non-fixed part of
IL-8 were considered) and computation time (computation-
ally expensive updates of non-bonded contacts between
the fixed atoms are avoided) without compromising the
accuracy of the resulting structures.
In total, 63 restraints were identified within the bound
peptide, 222 restraints were identified involving the HN
atoms of IL-8 residues 8–21 and 39–50, and 57 NOEs
were observed between the peptide and IL-8 (Table 1).
This corresponds to 8.0 distance restraints per residue that
is allowed to move during the annealing process. In this
way 40 structures were calculated (each with a different
starting position for the peptide), and the resulting 20
structures with lowest restraint violation energy were used
to represent the structure of the CXCR1-p1–IL-8 complex.
These structures satisfy the input restraints very well,
having no single violations of the input distances greater
than 0.18 Å, no restraints consistently violated by more
than 0.1 Å in all structures, and reasonable values for the
other energetic terms in the force field (Table 2).
The final ensemble of structures is shown in Figure 5. As
expected from the input data, only the C-terminal half of
the peptide interacts with IL-8; residues Met1 to Met8 of
the peptide are disordered in the ensemble. All three
proline amide bonds of the peptide are present in the trans
orientation. The C-terminal part of the peptide sits in the
cleft defined by the chemical-shift changes (Figure 3) and
is approximately antiparallel to the N loop. When the
structures are overlaid on the portions of IL-8 that are kept
fixed during the refinement process, the backbone atom
root mean square (rms) displacement from the mean struc-
ture is 4.0 ± 4.0 Å for all peptide residues, but 1.14 ± 0.66 Å
for residues Pro9 to Pro17 (Figure 6a). The backbone
atoms of IL-8 that are free to move during the refinement
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Figure 4
Intermolecular NOEs observed between IL-8 and CXCR1-p1. (a) A
section of the F1 13C-edited, F3 13C-filtered NOESY spectrum
acquired on the CXCR1-p1–IL-8 complex in D2O solution [29].
Intermolecular NOEs between the Hα, Hδ and Hε atoms of Tyr15
(CXCR1-p1) and the IL-8 Lys11 Hδ (13C δ = 27.3 ppm) and Hβ (13C
δ = 33.5 ppm) atoms are shown in the upper and lower panels,
respectively. (b) Summary of all intermolecular NOEs observed
between IL-8 and CXCR1-p1. The lines indicate that at least one NOE
is observed between the residues that it connects.
have an rms displacement of 0.38 ± 0.37 Å from the mean
coordinates of the final ensemble and 1.00 ± 0.76 Å from
the initial IL-8 structure (Figures 6a and b).
Contacts between the peptide and IL-8 are predomi-
nantly hydrophobic in nature with Pro9 and Pro10 of the
peptide interacting with Tyr13, Phe17, Phe21, Leu43,
Arg47 and Leu49 of IL-8. Tyr15 of the peptide occupies
the remainder of the N-loop cleft and has contacts with
Ile10, Lys11, Tyr13 and Leu49. The C terminus of the
peptide wraps around the IL-8 β sheet with Pro17 contact-
ing Gln8, Ile10 and Ile40 of IL-8. These contacts can be
seen in the minimized mean conformation shown in
Figure 5b. The formation of this interface buries 670± 90 Å2
and 650 ± 90 Å2 of solvent-accessible surface on the IL-8
A chain and the peptide, respectively (Figure 6c). For com-
parison, this is slightly smaller than the interface buried
between the two IL-8 monomers in the free protein (710 Å2
in the NMR-derived minimized mean structure and 840 Å2
in the X-ray crystal structure).
The ensemble shows that the peptide is in a relatively
extended conformation in the cleft, in agreement with the
lack of long-range, intrapeptide NOEs in the transferred
NOE experiments. The lack of specific contacts between
the N terminus of the peptide and IL-8 also explains the
small ‘footprint’ identified by the chemical-shift changes
observed as peptide is bound. The sidechain–sidechain
nature of the interaction also explains the lack of inter-
molecular NOEs observed in the 15N-filtered and edited
NOESY experiments discussed above. An exhaustive analy-
sis of the final ensemble identifies only a handful of inter-
molecular contacts involving amide protons. The average
proton–proton separations are 4–5 Å, hence the observa-
tion of such contacts may be limited by the sensitivity of
the NOESY experiments.
In addition to hydrophobic contacts, the structures suggest
that intermolecular charge–charge interactions may also
occur between Asp12, Glu13 and Asp14 of the peptide and
Lys15, Arg47 and Lys11, respectively, of IL-8 (Figures 5b
and c); although the conformations of these sidechains are
not well defined in the current calculations, many members
of the ensemble do have these residue pairs in close prox-
imity. As the peptide directs its sidechains towards IL-8
there is little possibility for intermolecular hydrogen-bond
interactions from the peptide mainchain atoms. Of the
polar sidechain groups in the peptide, Tyr15 is largely
buried in the complex, but the sidechain is oriented such
that the hydroxyl group is exposed to solvent at the edge
of the binding cleft. 
Discussion
Peptide analogs
The ability of alanine analogs of CXCR1-p0 (Figure 1b) to
prevent IL-8 from binding to neutrophils was reported
recently [22]. These experiments indicated that changing
residues corresponding to Pro9, Tyr15 and Pro17 to
alanine had the largest effects on IC50 (31-, 20- and 12-fold
increases, respectively), suggesting that the hydrophobic
contacts made by these residues are indeed important for
affinity. Replacement of the three acidic residues Asp12,
Glu13 and Asp14 each caused a twofold to fourfold increase
in IC50, suggesting that the possible ionic contacts discussed
above make small contributions only to the binding energy. 
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Table 1
Summary of distance restraints used to calculate the structure
of the IL-8 complex.
IL-8† Peptide Total
Intramolecular*
total 222 63 285
intraresidue 75 35 110
sequential 60 19 79
medium-range 33 7 40
long-range 54 2 56
Intermolecular
57
*NOE restraints are only counted if they are deemed structurally useful,
that is, if the corresponding upper bound is shorter than that allowed
by covalent geometry; all intraresidue NOEs and sequential NOEs to
HN were checked to see if they met this criterion. †Only restraints
involving HN of residues 8–21 and 39–50 of IL-8 were included in the
refinement (see text).
Table 2
Restraint violation and energy statistics for the ensemble of
IL-8 complex structures.
Ensemble Minimized mean*
Energy (kcal mol–1)
Total –144.6 ± 11.0 –134.8
Nonbonded –140.8 ± 8.2 —149.0
Bond lengths 11.2 ± 0.3 10.5
Bond angles 64.2 ± 5.3 55.8
Torsions 56.0 ± 5.3 55.5
Out of plane 0.5 ± 0.1 1.7
Electrostatic –121.0 ± 6.6 –97.2
Hydrogen bond –14.7 ± 1.3 –12.2
Restraint violation 3.0 ± 0.6 2.5
NOE violations
Number > 0.0 Å 42.3 ± 5.2 41
Number > 0.1 Å 2.1 ± 1.1 1
Sum (Å) 1.68 ± 0.22 1.33
Maximum (Å) 0.14 ± 0.03 0.18
Dihedral angle violations
Number > 0° 17.1 ± 2.9 20
Number > 5° 0 0
Sum (°) 11.8 ± 2.9 9.4
Maximum (°) 2.5 ± 1.1 1.9
*Minimized mean structure derived from restrained energy minimization
of the geometric mean structure as described in the Materials and
methods section.
Alanine replacements at the N terminus of CXCR1-p0
resulted in twofold to fivefold increases in IC50, suggest-
ing that these residues make weak contacts with IL-8.
Additionally, N-terminal truncations of CXCR1-p0 caused
the IC50 to increase incrementally as residues 1 to 6 were
removed, but remained approximately constant (IC50 200-
fold higher than the initial 21-residue peptide) with the
removal of residues 7 to 12 (i.e. truncation up to and
including Met8 of CXCR1-p1). The combination of
peptide analog and NMR data suggest a binding mode in
which the C terminus of the peptide makes specific and
reasonably tight contacts with IL-8, whereas the N termi-
nus makes less specific, weaker contacts. These weaker
contacts may be ionic in nature given the acidic nature of
the N terminus of the peptide (three aspartate residues)
and the generally basic nature of IL-8; Lys20, Lys23 and
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Figure 5
Structure of the CXCR1-p1–IL-8 complex.
(a) Stereoview of the structure of the complex
formed between IL-8 and CXCR1-p1. The
parts of IL-8 monomer A that were allowed to
move during the refinement are shown in dark
purple, the fixed parts of IL-8 monomer A are
in light purple, IL-8 monomer B (fixed) is in
gray and the peptide is shown in cyan. The 20
structures of the ensemble are aligned using
atoms from the immobile IL-8 chain. 
(b) Minimized mean structure of the CXCR1-
p1–IL-8 complex. The IL-8 monomers are in
gray and purple and the peptide is in cyan.
The IL-8 residues surrounding the binding
cleft and the peptide residues buried at the
interface are shown in stick representation.
Intermolecular NOEs are observed to the dark
purple residues of IL-8. (Parts (a) and (b) were
created with the program InsightII [MSI, San
Diego].) (c) The solvent-accessible surface of
IL-8 and stick rendering of bound CXCR1-p1
(cyan). The IL-8 surface is colored according
to the electrostatic potential derived from the
charges of IL-8 only, and ranges from +10 kT
(blue) to –10 kT (red); the terminal atoms of
three acidic residues of CXCR1-p1 are
colored red. The orientation is the same as in
(a) and (b). (Part (c) was created using the
program GRASP [59].)
Arg68 of IL-8 are sufficiently close to the N-loop cleft that
they could easily be involved in such interactions.
Relevance of the structure
For any study of a receptor–ligand interaction in which one
of the components has been modified, the question of rele-
vance to the full-domain interaction must be considered. In
the present case, there are several lines of evidence to
suggest that the conformation determined for CXCR1-p1 in
complex with IL-8 is indicative of the way in which the
intact, membrane-bound receptor interacts with IL-8.
Within intact CXCR-1, alanine substitution of residues cor-
responding to Pro9 and Tyr15 in CXCR1-p1 lead to signifi-
cant decreases in the affinity of IL-8 for the mutated
receptors [18]. This is in agreement with the peptide analog
studies [22], and suggests that the peptide–IL-8 contacts
observed in the current structures are also likely to be
present when IL-8 binds to membrane bound CXCR-1.
Interestingly, changing Pro17 to alanine has little effect on
IL-8 affinity for the full-length receptor. In CXCR-1, Pro17
is followed by a disulfide-bonded cysteine residue, thus
some structural differences between the peptide and recep-
tor complexes might exist in this region. Alternatively, the
N-terminal fragment of the receptor may still bind as shown
in Figure 5, but the presence of the other extracellular loops
of the receptor alters the contribution that Pro17 makes to
the total binding energy. Thus, the biochemical data are in
agreement with the current structural data.
Although IL-8 is able to bind to both CXCR-1 and
CXCR-2 with high affinity (1–2 nM), melanoma growth
stimulating activity (MGSA), a close homolog of IL-8, only
binds to CXCR-2 with high affinity [31]. In addition,
MGSA does not interact with CXCR1-based peptides; the
IC50 for CXCR1-p0 inhibiting the binding of 125I-labeled
chemokine to CXCR-2 is >100-fold higher for MGSA
versus IL-8 (HBL and G Nakamura, unpublished data).
Lowman et al. have demonstrated that the source of this
specificity lies in the N-loop region; MGSA was altered to
bind tightly to both receptors by replacing seven N-loop
residues and one residue in strand β3 (Leu49, which packs
against the N loop) with the corresponding residues from
IL-8 [11]. The importance of the receptor N terminus for
ligand specificity has also been concluded from studies
with CXCR-1–CXCR-2 chimeric molecules [32].
The present results shed some light on the structural
basis for the relative specificities of CXCR-1 and CXCR-2
binding to IL-8 and MGSA. Of the chemokine sidechains
in contact with the peptide (Figure 5), there are signifi-
cant sequence differences between IL-8 and MGSA for
residues 13 (Tyr→Leu), 17 (Phe→Ile), 21 (Phe→Asn) and
49 (Leu→Ala). To facilitate estimation of the effect of
these substitutions, one member of the NMR ensemble
reported for MGSA (Protein Data Bank [PDB] accession
number 1MGS [33]) was overlaid with the ensemble of
IL-8 in complex with the peptide using residues 7 to 13 and
36 to 51 of IL-8. As MGSA has one less residue in the N
loop, the isoleucine residue of MGSA overlays with the ter-
minal atoms of Phe17, hence little peptide contact would
be lost from this mutation. However, the other three differ-
ences would lead to a significant decrease in van der Waal’s
contact between MGSA and the peptide (assuming that
CXCR1-p1 bound in the same conformation), which may in
part explain why MGSA does not bind tightly to CXCR-1. 
With regard to the receptors, the three proline residues
in contact with IL-8 are present in both CXCR-1 and
CXCR-2 (Figure 1). However, the residue in CXCR-2 cor-
responding to Tyr15 is alanine, which would be expected
to weaken the binding of CXCR-2 N-terminal peptides to
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Figure 6
Coordinate precision and buried surface area of the CXCR1-p1–IL-8
complex. (a) Plot of the root mean square (rms) deviation of N, Cα and
C coordinates from the mean structure of the IL-8 complex. (b) Plot of
the rms displacement of N, Cα and C coordinates of IL-8 in complex
with CXCR1-p1 versus free IL-8 in solution [30]. (c) Plot of the buried
surface area within the CXCR1-p1–IL-8 interface. Data for IL-8 chain A
and CXCR1-p1 are shown on the left and right, respectively.
IL-8; such a difference has been noted experimentally
[20]. Possibly, the interactions of Tyr15 are replaced by
one (or more) of the hydrophobic residues that are present
in CXCR-2 but not in CXCR-1 (e.g. the three residues fol-
lowing the Pro–Pro sequence; see Figure 1).
Model of the CXCR-1–IL-8 interaction
The data presented show that the N-terminal peptide of
CXCR-1 binds to the cleft between the N loop and strand
β3 of IL-8. However, the peptide binds to IL-8 with an
affinity three to four orders of magnitude weaker than that
of the full-length receptor, hence other extracellular por-
tions of the receptor must interact with IL-8. The impor-
tance of the ELR sequence of IL-8 is also not explained by
the present complex as this portion of IL-8 is not close to
the N-loop cleft or the bound peptide (the distance from
Arg6 Cα of IL-8 to Pro17 Cα of CXCR1-p1 is ~12 Å in the
final ensemble). Alanine-scanning mutagenesis of the extra-
cellular loops of CXCR-1 indicate that Arg199 and Arg203
in the third extracellular loop and Asp265 in the fourth
extracellular loop are critical for IL-8 binding and calcium
mobilization, whilst many other residues in these loops
have partial effects on IL-8 binding [18]. A simple explana-
tion of these results is a model in which the N loop of IL-8
interacts with the receptor N-terminal peptide, whereas the
ELR sequence of IL-8 interacts with extracellular loops 3
and 4 of the receptor (Figure 7). The latter interaction
could be charge-mediated (Glu4 of IL-8 interacting with
Arg199 and Arg203 of the receptor, and Lys6 of IL-8 inter-
acting with Asp265 of the receptor), but may also involve
hydrophobic contacts as suggested by Leong et al. [18].
Besides receptor contacts, IL-8 has also been shown to bind
to sulfated cell-surface glycosaminoglycans [34]. This event
allows a haptotactic chemokine gradient to be established
on endothelial cells [35,36]; without such a presentation
mechanism, activation of neutrophils would occur in the
blood stream rather than at the site where extravasation to
the underlying tissue is required. Basic residues on IL-8 are
localized to the helix side of the IL-8 dimer, and are respon-
sible for association with the sulfate groups of the gly-
cosaminoglycan [37]. Binding to heparin-like molecules on
endothelial cells via the helix of IL-8 allows presentation in
such a way as to allow the ELR sequence and the N-loop
cleft to interact with receptor molecules on passing neu-
trophils (Figure 7). Thus, the present structural data can be
augmented by a variety of biochemical restraints to propose
the low-resolution model of the initial step of activation of
neutrophils by IL-8. Note that the oligomerization state of
IL-8 required for function in vivo is not known. The self-
association of IL-8 is such that it is monomeric at the low
nanomolar concentrations present in vivo [38], and synthetic
monomeric derivatives of IL-8 are active in vitro [6,7].
However, covalent dimers of IL-8 are active in vitro [39],
and Hoogewerf et al. have recently demonstrated that gly-
cosaminoglycans promote self-association of several chemo-
kines, and thus multimeric forms may be presented from
the endothelial cell surface in vivo [40]. The model pro-
posed in Figure 7 is equally valid for a monomeric or
dimeric chemokine ligand.
Interactions of other chemokines with their receptors
The available structures indicate a common tertiary struc-
ture for all chemokines in spite of the wide diversity of
their amino acid sequences. The hydrophobic residues in
the N-loop cleft of IL-8 (Ile10, Ile40, Leu43 and Leu49)
have a similar nonpolar character in all CXC chemokines;
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Figure 7
Model for the presentation of IL-8 by endothelial cell-surface
glycosaminoglycans to the CXCR-1 receptor on a passing neutrophil.
The structural details from the present manuscript are shown with
purple (IL-8) and blue (CXCR1-p1) tubes. CXCR-1 is shown
schematically in blue, with the ELR sequence of IL-8 (in yellow)
pointing towards extracellular loops 3 and 4 of the receptor. The basic
residues of IL-8 that interact with heparin fragments (dark purple) [37],
are shown interacting with a schematic glycosaminoglycan (black) on
the endothelial surface.
these amino acids are more diverse in the CC chemokine
sequences, but generally still hydrophobic. Thus, a
hydrophobic cleft between the N loop and the β2–β3
hairpin is probably present in all chemokine molecules,
providing an attractive site for receptor interaction. 
Interestingly, the N-terminal 32 residues of the receptor
CCR-2b are capable of binding to monocyte chemoattrac-
tant protein-1 (MCP-1) with an affinity equivalent to that
of the full-length receptor [41], suggesting that the inter-
action of the N-terminal receptor peptide with the N-loop
cleft is an important feature of many chemokine–receptor
binding events. Recent studies have shown that residues
in the N-terminal portion of chemokine receptors are also
necessary for receptor binding to gp120, the membrane
glycoprotein of HIV-1, thereby facilitating viral entry into
cells [42]. Sequestration of the receptor N terminus by
chemokine binding suggests one mechanism by which
chemokines may prevent HIV-1 infection of cells [43]. We
note, however, that the N-terminal residues of chemokine
receptors are not highly conserved, and of the sidechains
buried in the CXCR1-p1–IL-8 complex (Pro9, Pro10,
Tyr15 and Pro17), only Pro17 is conserved across most
of the receptors. Furthermore, in the structures of CC
chemokines determined to date [5], the N terminus of one
molecule comes into close proximity to the N-loop cleft of
the other molecule in the dimer. Thus, if the N-terminal
strands of other receptors do sit in the N-loop groove of
their cognate ligands, the exact mode of interaction will
differ from that described herein for the complex between
IL-8 and CXCR1-p1.
Biological implications
The activation of leukocytes and their recruitment to
target sites on the endothelium are vital to the mainte-
nance of an inflammatory response, both in host protec-
tion and disease. The interaction of chemokines with their
receptors is one of several known intercellular contacts
responsible for these events; the receptors are G-protein-
coupled and reside in the leukocyte membrane, whereas
the chemokines are transiently anchored to the endothe-
lial cell surface by interactions with glycosaminoglycans.
Although the structures of many chemokines have been
determined, to date the membrane-bound nature of the
receptors has precluded a detailed structural understand-
ing of the ligand recognition process. 
The present study has defined at an atomic level the
interaction between a chemokine, interleukin-8 (IL-8),
and a portion of a chemokine receptor that is found on
neutrophils (a peptide based on the N terminus of the
receptor CXCR-1). Residues corresponding to Pro21–
Pro29 of CXCR-1 occupy a hydrophobic groove between
a loop (the N loop) and a β hairpin of IL-8. This mode
of binding is also likely to be present in the binding of
full-length receptor to IL-8. The present structure only
includes part of the receptor–ligand interface, but we
extrapolate from it by consideration of other biochemical
data to propose a model for the interaction of the intact
receptor with IL-8. This model is also compatible with
the role of endothelial cell glycosaminoglycans, which
present the chemokine for interaction with cell-surface
receptor molecules on passing neutrophils.
Structural and sequence similarities imply that this
mode of binding may also be adopted by other chemo-
kine–receptor pairs, although differences in sequence
may alter the exact details of the interaction and provide
a basis for receptor–ligand specificity. The current struc-
ture identifies several specific interactions of the recep-
tor peptide with IL-8 that will be of use in the structure-
based design of non-peptidic IL-8 antagonists. Such
molecules may have a role in combating inflammatory
disease by inhibiting the unwanted association of neu-
trophils to the endothelial cell surface, thereby reducing
damage to host tissue.
Materials and methods
Sample preparation
IL-8 was overexpressed in Escherichia coli and purified by a variation
of previously described protocols [11,44]. Cells were grown overnight
at 30°C on the 15N/13C low-phosphate medium described in [44] sup-
plemented with 0.5% (w/v) CELLTONE-CN powder (Martek Corp.,
Columbia, MD), prior to transfer to minimal, low-phosphate, media con-
taining 15NH4Cl and 13C glucose for final protein production. The result-
ing cells were centrifuged and the pellet and supernatant stored at
–20°C. The supernatant was thawed at 23°C, sterile filtered and
loaded onto an 8 ml S-sepharose (Pharmacia) column and developed
with a linear gradient of 0.15 M to 1.0 M NaCl in 10 mM sodium phos-
phate buffer at pH 7.4. Protein was also extracted from the cell pellet at
0°C under three sets of conditions: low salt conditions (10 mM Tris
pH 7.6, 1 mM EDTA, 0.1 M phenylmethylsulfonyl fluoride [PMSF], 0.5 mM
benzamidine); high salt conditions (300 mM NaCl, 22% sucrose,
10 mM EDTA, 0.1 M PMSF, 0.5 mM benzamidine, 45 mM Tris pH 8.0);
and high salt conditions with lysozyme (0.1 mg/ml). In all cases
S-sepharose purification was performed as described above.
The single-peak fractions from each of the S-sepharose columns were
diluted to 0.15 M NaCl with 10 mM phosphate buffer, and the IL-8 was
concentrated in five runs on a 1 ml S-sepharose column, developed as
above. The peak fractions were pooled, adjusted to 60% saturated
ammonium sulfate, and loaded in three runs onto a phenylsuperose
(Pharmacia) FPLC column. IL-8 was eluted with a linear gradient of
64–0% ammonium sulfate in 50 mM sodium phosphate pH 7.4. The
peak fractions were pooled and buffer-exchanged by repeated dilution
with 50 mM sodium phosphate buffer pH 5.5 followed by concentra-
tion on a Centriprep-3 (Amicon). The final yield, as estimated by the
A280, was 34 mg, corresponding to 53% of the initially extracted IL-8.
CXCR1-p1 peptide was synthesized manually using Fmoc-based solid-
phase synthesis with a Rink-amide resin. Upon completion of synthesis,
sidechain protection groups were removed and the peptide cleaved
form the resin with 95% trifluoroacetic acid (TFA), 5% triisopropylsi-
lane. Purification was performed by reverse-phase HPLC with a water–
acetonitrile gradient containing 0.1% TFA. The peptide was deter-
mined by analytical HPLC to be greater than 95% homogeneous and
its identity was verified by mass spectrometry.
IL-8 samples for NMR analysis consisted of 440µl of a 2.0 mM solution
of IL-8 monomer in 50 mM phosphate buffer at pH 5.5 containing 10%
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D2O (v/v). This sample was used to assign the 1H, 13C and 15N reso-
nances of free IL-8. Samples of CXCR1-p1 were prepared in the same
buffer at a concentration of 6.4 mM. The complex was formed by adding
15 µl aliquots of the peptide to the IL-8 sample. Chemical shifts stopped
changing after 11 such additions, corresponding to 1.2 equivalents of
peptide per IL-8 monomer. This sample was lyophilized and resuspended
in 440 µl of 90% H2O (complex concentration 2.0 mM monomer).
HSQC spectra (see below) acquired before and after lyophilization were
identical, suggesting that lyophilization and the slight increase in buffer
concentration (50 to 70 mM) did not have a deleterious effect on the
complex or the resonance positions. The majority of NMR data described
below were collected with this sample. Spectra were also acquired after
this sample was lyophilized and resuspended in 440µl of D2O.
NMR spectroscopy
All spectra were acquired at 308K on a Bruker AMX-500 spectrometer
equipped with four radio frequency channels, a triple resonance inverse
detection probe and a triple axis pulsed-field gradient amplifier. 1H
chemical shifts were referenced relative to internal DSS at 0.0 ppm;
13C and 15N chemical shifts were referenced indirectly [45]. 
15N HSQC and 13C CT-HSQC experiments were performed as
described in [46]. For the former, decoupling was achieved by a hard
13C 180° pulse centered at 125 ppm applied at the mid point of t1 and
15N GARP composite pulse scheme during t2; in the latter experiments,
15N WALTZ composite pulse decoupling was applied during the 13C
constant time period, and a 13C GARP composite pulse decoupling
scheme was applied during t2.
The triple resonance experiments HNCA, HN(CO)CA, HNCO and
HCCH-TOCSY were acquired in H2O solution on free IL-8 and the
IL-8–peptide complex, as described in [46] with 15N constant time
period (27 ms) and broadband proton decoupling to prevent creation of
antiphase heteronuclear components. CBCA(CO)NH spectra were
acquired as described by Grzesiek and Bax [47] with gradient selection
of the final 15N–1H coherences [48]. HNCACB experiments were
acquired as described by Wittekind and Mueller [49] with seduce car-
bonyl decoupling throughout [50]. Aromatic resonances of free and com-
plexed IL-8 were obtained from 13C CT-HSQC (constant time periods of
16.6 or 33.2 ms) and 1H TOCSY-relayed 13C CT-HMQC experiments
(constant time periods of 16.6 or 33.2 ms and 1H mixing for 13 ms) [51].
NOEs within IL-8 in the complex were identified in a  three-dimensional
(3D) F2 15N-edited NOESY-HSQC (τm = 100 ms [46]) employing 13C
decoupling (180° pulse during t2, GARP composite decoupling during
t3) and gradients for 15N–1H coherence selection [48].
COSY, NOESY (τm = 300 ms), TOCSY (τm = 83 ms) and ROESY
(τm = 200 ms; 4 kHz field strength) spectra were collected on the free
peptide in H2O solution as described in [46] with solvent suppression
achieved by excitation sculpting [52]. Spin systems and NOEs involv-
ing the peptide HN protons were obtained in the complex by the use of
TOCSY (τm = 60 ms) or NOESY (τm = 100 ms) experiments with an
15N spin-echo prior to t2 [53]. Peptide aliphatic sidechain assignments
in the complex were confirmed in D2O solution by acquisition of F2
13C-filtered 1H TOCSY spectra (τm = 36 or 65 ms) with purge pulses
double-tuned to 1JC–H of 140 and 125 Hz [29]. An F1, F2 13C-filtered
1H NOESY (τm = 100 ms) was also acquired with the same purging
scheme. Intermolecular NOEs were identified in a 3D F1 13C-edited, F3
13C-filtered NOESY experiment acquired from D2O solution [29].
A list of data collected and experimental parameters is provided together
with a list of all assigned chemical shifts in the complex as supplementary
material available on the internet with the electronic version of this paper.
Data processing and analysis
The spectra were processed and analyzed using Felix (MSI, San Diego,
CA). Prior to Fourier transformation, each free induction decay (FID)
was corrected for direct current offset using the final 5% of the FID, the
first point was linear predicted and halved in intensity [54], and the FID
multiplied by a weak Lorentzian-to-Gaussian window function. In the
indirectly detected dimensions, the first point of cosine modulated data
was multiplied by 0.5 and the interferogram multiplied by a cosine bell
followed by the application of a weak Lorentzian-to-Gaussian function;
the interferograms of the heteronuclear dimensions of triple resonance
experiments were extended by linear prediction by up to 50%.
Distance restraints
Distance restraints were obtained from: 15N-filtered 2D NOESY (H2O,
intramolecular, peptide); F1, F2 13C-filtered 2D NOESY (D2O, intramol-
ecular, peptide); F2 15N-edited 3D NOESY-HSQC (H2O, intramolecu-
lar, IL8) and the F1 13C-edited, F3 13C-filtered 3D NOESY (D2O,
intermolecular). Cross-peaks were categorized as strong, medium,
weak or very weak on the basis of the integrated volume and assigned
upper bounds of 3.0 Å, 3.5 Å, 4.2 Å or 5.0 Å, respectively. In all spectra,
the restraint distance used for overlapped cross-peaks was increased
by one category or set to the maximum upper bound depending on the
severity of the overlap. Cross-peak volumes involving methyl groups,
degenerate methylene resonances and protons of rapidly flipping aro-
matic sidechains were divided by the number of protons contributing to
the resonance before categorization [55].
Calculation of structures
Initial conformations for the complex were prepared using the mini-
mized mean structure of IL-8 (PDB accession code 1IL8 [30]) and a
linear extended model of the peptide built within the program InsightII
(MSI, San Diego). One copy of the peptide was randomly oriented with
respect to the IL-8 dimer to generate 40 starting conformations. Each
of these structures were optimized using a restrained molecular dynam-
ics (rMD) protocol in which all peptide residues, and residues 8 to 21
and 39 to 50 of the IL-8 monomer closest to the peptide were allowed
to move, and all other parts of the IL-8 dimer were kept fixed. Several
IL-8 residues neighboring the set that undergo chemical-shift changes
were allowed to move during the refinement so as to minimize any per-
turbations of the CXCR1-p1-binding site by backbone connections to
the fixed portion of IL-8. 
Calculations were performed with the AMBER all-atom force field
[56] using the DISCOVER package (MSI, San Diego). The dielectric
constant was set to 4*r where r is the distance between the interacting
atoms, and partial atomic charges on lysine, arginine, glutamyl and
aspartyl sidechains were reduced to give a total charge of 0.2. Experi-
mental NOE restraints were enforced by flat-bottomed square-well
potentials with force constants of 25 kcal mol–1 Å–2. Restraints were
also included to enforce the peptide bonds to be within 10° of pla-
narity, to maintain peptide phi angles in the range –180° to 0°, and
to enforce aromatic rings to within 2° of planarity (force constant
100 kcal mol–1 rad–2). The rMD was performed with a non-bonded cut-
off of 12 Å and a time step of 0.5 fs. The structures were warmed to
900K over 1500 steps and then maintained at this temperature for
4000 steps before slowly cooling back to 0K over 8000 steps; the
experimental restraint force constants were increased from 0 to the
maximal values over the first 2500 steps of this scheme. The annealing
cycle was preceded and followed by restrained energy minimization
(100 cycles of steepest descents and 400 cycles of conjugate gradi-
ents). A minimized mean structure was generated by subjecting the
geometric mean structure to 5000 cycles of energy minimization with
the experimental restraints enforced as described above. 
Analysis of the structures
The structures were visually inspected using InsightII. A search was
made for intermolecular contacts involving HN and Hα groups of
CXCR1-p1 with a series of AWK scripts. Solvent-accessible surface
areas were calculated for the final 20 structures in the complex and for
the individual components in the bound conformation using a probe of
1.4 Å radius.
Accession numbers
The 20 structures with lowest restraint violation energy and the mini-
mized mean structure have been submitted to the PDB with accession
codes 1ILP and 1ILQ, respectively.
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Supplementary material
Supplementary material available on the internet with the electronic
version of this paper contains a list of all NMR experiments (including
spectral parameters) performed on IL-8 complexed with CXCR1-p1
and a list of all assigned chemical shifts in the complex.
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